Coming Soon!
Emerging Firms
Accounting Firms
Banks, Insurance
Real Estate Developers
Hospitals
Hotels & Restaurants
Media
Arts Leaders
Science Leaders
Government and Politics
       |
   
     
|
Venture Capital Firms and Investment Banks D-I
| DeMuth, Folger & Wetherill |
| Glenpointe Centre East |
| Fifth Floor |
| 300 Frank W. Burr Boulevard |
| Teaneck, NJ 07666 |
| Phone: (201) 836-6000 |
| Fax: (201) 836-5666 |
| email: info@dfwcapital.com |
| Web Site: http://dfwcapital.com |
| Donald F. DeMuth Partner |
| Founded 1983, manages three private equity investment partnerships providing equity capital for high growth market niche companies> Prefers to act as lead investor, with board representation, generally invests between $3 million and $10 million per transaction, substantially greater funding also available through significant institutional limited partners> Target investments in firms with $10 to $75 million in revenues and enterprise values under $100 million> Preferred industries healthcare services; business services, with emphasis on companies in outsourcing; consumer services; specialty manufacturing; and value-added distribution> Will not invest in research and development companies, but will invest in service businesses applying technology in proprietary ways> Past investments include IEC Electronics (Newark, contract electronics manufacturing); Micrion (semi-conductor production equipment); Oriel (electro-optic instruments manufacturing and catalog sales); Premier Medical Services (home healthcare personnel and catalog sales)> Principals include Thomas DeMuth, formerly at Kidder Peabody in investment banking and chair of its audit committee; Thomas W. Folger, also former Kidder Peabody investment banker and head of its research department; David Wetherill, over 20 years in health care industry with SmithKline Beeecham, BOC GROUP, National Medical Care and Avon Health Care; Lisa Roumell, formerly with First Century Partners specializing in investments in consolidating industries. |
| Domain Associates |
| One Palmer Square |
| Princeton, NJ 08542 |
| Phone: (609) 683-5656 |
| Fax: (609) 683-9789 |
| Web Site: http://www.domainvc.com |
| James C. Blair General Partner |
| Preferred venture investment over $1 million in seed, first-stage, leveraged buyouts> Functions either as deal originator or participant in deals originated by others> Focus on life sciences, molecular engineering, animal and human health care, agriculture and food technology, biomedical instruments, toxic material degradation, medical diagnostics> Invests approximately $25-30 million annually> Office also in Costa Mesa, CA> Investments include DNX (transgenic animals), Oncotherapeutics (Cranbury, anti-cancer drugs); Chimeric Therapies, (tissue engineering and patient conditioning technologies to enable successful bone marrow and solid organ transplants between mismatched donors and patients); Connetics (acquisition and development of medicines in rheumatology and dermatology); Vista Medical Technologies (develops, manufactures, and markets proprietary 3-D visualization and information systems enabling minimally invasive surgical solutions)> Partners include James C. Blair, former managing director of Rothschild-New Court venture capital, and associate with F.S. Smithers and White, Weld & Co. investment bankers, Ph.D. and M.S.E., University of Pennsylvania, B.S.E., PRINCETON UNIVERSITY; Brian H. Dovey, past president of Rorer Group, also president Survival Technology, M.B.A. Harvard Business School, B.A. Colgate University; Jesse Treu, also serves as board chairman of CHRYSALIS INTERNATIONAL, previously with Channing Weinberg and Co. investment and venture capital firm, also technical, strategic planning positions with Technicon Corp, General Electric, Ph.D., M.S. PRINCETON UNIVERSITY, B.S. Rensselaer Polytechnic Institute; Richard S. Schneider, formerly with 3i Ventures venture capital firm and Biomedical Consulting Associates, Ph.D. University of Wisconsin, B.S. University of California> Kathleen K. Shoemaker, CPA, formerly with KPMG PEAT MARWICK, M.B.A. New York University M.A. Middlebury College, B.A. Wheaton College. |
| Early Stage Enterprises |
| 995 Route 518 |
| Skillman, NJ 08558 |
| Phone: (609) 921 8896 |
| Fax: (609) 921 8703 |
| e-mail: partners@esevc.com |
| Web Site: http://www.esevc.com |
| Ronald R. Hahn Partner |
| Private venture capital fund organized to provide capital and guidance to early stage companies in Mid-Atlantic region> Licensed Small Business Investment Company with $44 million to invest> Founded 1996 by Ronald R. Hahn and James J. Millar to focus on investing in companies requiring less than $2 million of capital, preferred investment $500,000 to $1 million, but also considers investing as little as $250,000 in companies with exceptional growth potential> Typical prospective companies have less than $3 million of annual revenues at time of first investment> Ronald R. Hahn previously officer and/or General Partner of four venture capital organizations, including Heizer Corporation, major Chicago-based venture capital firm, Commodities Corporation in Princeton serving as First Vice President and Treasurer, founder of Princeton/Montrose Partners, venture capital partnership specializing in life science technology, agribusiness, food, energy and natural resource related investments, Alan Patricof Associates in NY City as a General Partner on health-care team, B.A. Occidental College, M.B.A. Anderson School of Management, UCLA; James J. Millar began career at Texas Instruments in number of engineering and management positions, later worked with Philadelphia Ventures while attending Wharton School of University of Pennsylvania, spent 12 years with DSV Partners venture capital fund in Princeton, General Partner leading early stage investments in software and communication fields, M.B.A. with distinction Wharton School, B.S. in Engineering and Applied Science, Yale University. |
| Edelson Technology Partners |
| 300 Tice Boulevard |
| Woodcliff Lake, NJ 07675 |
| Phone: (201) 930-9898 |
| Fax: (201) 930-8899 |
| e-mail: webmaster@edelsontech.com |
| Web Site: http://www.edelsontech.com |
| Harry Edelson Managing Partner |
| Established 1984, venture capital firm with over $100 million under management> Corporate investors include AT&T; FORD MOTOR CO.; COLGATE-PALMOLIVE> Preferred investments over $1 million in start-up, later-stage or leveraged buyouts in technology, including satellite and microwave communications; data and telecommunications; fiberoptics; genetic engineering; industrial automation> Over $70 million capital under management> Founder Harry Edelson former senior systems computer engineer for Unisys, transmission engineer for AT&T, director of management information systems for Cities Service and director of marketing for terminal manufacturer, securities analyst on Wall Street covering computers, telecommunications, and office equipment. |
| Edison Venture Fund |
| 1009 Lenox Drive #4 |
| Lawrenceville NJ 08648 |
| Phone : (609) 896-1900 |
| Fax: (609) 896-0066 |
| e-mail: info@edisonventure.com |
| Web Site: http://www.edisonventure.com |
| John H. Martinson Managing Partner |
| Established in 1986, Edison Venture Fund provides private equity and value-added services to growing information technology companies. Edison invests in expansion stage ($5 to 20 million revenue) companies located in the New York City to Virginia corridor. Initial investments range from $3 to 6 million. Edison typically serves as a sole or lead investor> Currently has $400 million under management and is actively making new investments> Capital pool exceeds $280 million in four independent limited partnerships> General Partner s include JOHN MARTINSON, formerly with Innoven Group venture capital, current chairman, National Venture Capital Association, founder and past chairman, NJ TECHNOLOGY COUNCIL, M.B.A. Southern Illinois University, M.S. Purdue, B.S. US Air Force Academy; James Gunton, formerly with Price Waterhouse and Oracle, focuses on identifying NJ investment opportunities, director of NJ Entrepreneurs Network, M.B.A. Duke University and B.S. Computer Science, Stanford University; Ross T. Martinson, formerly with Kidder Peabody, American Express and ARTHUR ANDERSEN, CPA, M.B.A. New York University, B.A. Yale University. |
| First Princeton Capital Corporation |
| 1 Garrett Mountain Plaza |
| West Paterson, NJ 07424 |
| Phone: (973) 278-8111 |
| Fax: (973) 278-4290 |
| Michael Lytell President |
| Preferred investment $100,000 - $250,000 in second-stage financings or leveraged buyouts> Industries include consumer products; retailing; restaurants; communications; electronic components> Small Business Investment Company> Participates either as deal originator or secondary investor> $3 million capital under management. |
| Founders Court |
| 12 North Main Street |
| Pennington, NJ 08534 |
| Phone: (609) 730-1700 |
| Fax: (609) 730-1986 |
| Nixon W. Hare President |
| Primary interest leveraged management buyouts of privately-held middle-market firms with $25-300 million in annual revenue> Affiliated with British merchant bank, Brown Shipley & Co,, Ltd., a subsidiary of Kredietbank Luxembourg> Investments usually in traditional manufacturing industries with strong market niche> Financed buyout of former Essex Chemical Co.; Prince Gardner leather goods> Principals include Nixon W. Hare, formerly with Citibank, J. Henry Schroeder Bank & Trust Co., United Jersey Bank (now SUMMIT BANK). |
| Geocapital Partners |
| 2 Executive Drive |
| Suite 820 |
| Fort Lee, NJ 07024 |
| Phone: (201) 461-9292 |
| Fax: (201) 461-7793 |
| Web Site: http://www.geocapital.com |
| Stephen J. Clearman Partner |
| Venture capital investments in information technology and services industry, computer software, Internet and electronic commerce, data processing services, database information providers> $500 million under management across North America and Europe, office also in London> Typically invests in rapidly growing companies with revenue between $2 million and $40 million, initial investment size ranges from $5 million to $20 million in start-ups, leveraged buy-outs, acquisitions> Stephen Clearman formerly partner with Adler & Co., J.D. Harvard Law School, Columbia (M.S. electrical engineering), Haverford College (B.A. mathematics). |
| Alan I. Goldman & Associates |
| 497 Ridgewood Avenue |
| Glen Ridge, NJ 07028 |
| Phone: (973) 857-5680 |
| Fax: (973) 509-8856 |
| Alan I. Goldman |
| Principal |
| Venture capital, investment banking and consulting firm> Prefers to act as deal originator for second-stage of mezzanine financing, minimum investment $250,000, preferred investment over $500,000 in companies with $500,000 or above in annual revenue> Industry preferences include communications; broadcasting; chemicals; computer hardware and software; medical and health; electronic instruments> Founded 1990, Alan Goldman formerly with Goldmark Partners, Coaxial Communications, Lehman Brothers; Jerome Shiloff formerly with Goldmark Partners, Stouffer Chemicals, DU PONT. |
| Gund Investment Corporation |
| 14 Nassau Street |
| Princeton, NJ 08542 |
| Phone: (609) 921-3633 |
| Fax: (609) 921-7697 |
| Gordon Gund President |
| Private investment firm of Gordon Gund, principal owner of Cleveland Cavaliers National Basketball Association team and member of Board of Governors of National Basketball Association, Cleveland Rockers Womens National Basketball Association franchise, San Jose Sharks National Hockey League team also principal owner and chairman of Nationwide Advertising Service, Inc. and director of Kellogg Company and Corning> Gund also prominent philanthropist, blind since 1970 from retinitis pigmentosa, co-founder with wife and chairman of The Foundation Fighting Blindness, leading private supporter of research focused on discovering causes, treatments, preventions and cures for retinitis pigmentosa, macular degeneration, Usher syndrome, and other retinal degenerative diseases> Investments include Align Technology, Silicon Valley company developed invisible alternative to orthodontic braces. |
| Health Care Ventures |
| 44 Nassau Street |
| Princeton, NJ 08542 |
| Phone: (609) 430-3900 |
| Fax: (609) 430-9525 |
| James H. Cavanaugh, Ph.D. President |
| Largest health care venture capital firm in world with over $350 million in capital, also provides consulting services in business strategies, mergers and acquisitions, assists companies seeking licensing partners in US, Europe, Japan> Formerly Healthcare Investment Corporation, changed name 1997 and relocated offices from Edison to Princeton, office also in Cambridge, MA> Special interests in early stage, mature turnaround investments in molecular biology, transplant medicine, endocrine and reproductive medicine, genetic screening and therapy, physiological monitoring with markets exceeding $300 million, annual revenue potential $50-100 million> NJ investments include GynoPharma (Somerville, women's health care); OSTEOTECH (Shrewsbury, bone, tissue grafts); PharmaGenics (Allendale, cancer, virus drugs)> Principals include President James H. Cavanaugh, Ph.D., formerly president of SmithKline Beckman pharmaceutical division, special consultant to President Reagan, staff assistant to President Nixon for health affairs, Ph.D., M.S. University of Iowa; Harold R. Werner, past director of new ventures for JOHNSON & JOHNSON Development Corp., M.B.A. Harvard University, M.S., B.S. PRINCETON UNIVERSITY. |
| Investment Partners Capital and Management Corporation |
| 732 West 8th Street |
| Plainfield, NJ 07060 |
| Phone: (908) 561-3622 |
| Fax: (908) 561-2596 |
| Frank J. Abella
Jr. President |
| Venture capital firm with preferred investments $500,000 plus in high-tech, health care, communications, finance, publishing and natural resources. |
| Go to Venture Capital A-C | Go to Venture Capital D-I | Go to Venture Capital J-P | Go to Venture Capital R-Z |
JOSHUA
//
Communications, Inc.
|
Copyright 2000-04 Joshua Communications, Inc.